Clinical trial
Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients
NCT00491140 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- June 30, 2008
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.